{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:08:03Z","timestamp":1784718483924,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Teva Branded Pharmaceutical Products R&D"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jad.2016.02.050","type":"journal-article","created":{"date-parts":[[2016,2,28]],"date-time":"2016-02-28T17:07:14Z","timestamp":1456679234000},"page":"51-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Long-term safety and efficacy of armodafinil in bipolar depression: A 6-month open-label extension study"],"prefix":"10.1016","volume":"197","author":[{"given":"Terence A.","family":"Ketter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jess","family":"Amchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Frye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2016.02.050_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0165-0327(94)00074-J","article-title":"Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis","volume":"33","author":"Ahrens","year":"1995","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.02.050_bib2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1017\/S1092852900014681","article-title":"Suicide in bipolar disorder: risks and management","volume":"11","author":"Baldessarini","year":"2006","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2016.02.050_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1399-5618.2006.00344.x","article-title":"Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review","volume":"8","author":"Baldessarini","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2016.02.050_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-0447.2011.01818.x","article-title":"Predominant recurrence polarity among 928 adult international bipolar I disorder patients","volume":"125","author":"Baldessarini","year":"2012","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2016.02.050_bib5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0165-0327(00)00247-0","article-title":"Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study","volume":"65","author":"Bauer","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.02.050_bib6","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.4088\/JCP.13m08951","article-title":"Efficacy and safety of armodafinil for the adjunctive treatment of major depressive episodes associated with bipolar I disorder: a randomized, double-blind, placebo-controlled; multicenter trial","volume":"75","author":"Calabrese","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2016.02.050_bib7","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1399-5618.2007.00507.x","article-title":"Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data","volume":"9","author":"Calabrese","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2016.02.050_bib8","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4088\/JCP.v65n1109","article-title":"Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample","volume":"65","author":"Calabrese","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2016.02.050_bib9","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4088\/JCP.09m05900gry","article-title":"Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study","volume":"71","author":"Calabrese","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2016.02.050_bib10","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0025-6196(11)60666-6","article-title":"Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study","volume":"84","author":"Czeisler","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jad.2016.02.050_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2147\/NDT.S41557","article-title":"Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study","volume":"9","author":"Fornaro","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2016.02.050_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40345-015-0034-0","article-title":"Randomized, placebo-controlled, adjunctive study of armodafinil for bipolar I depression: implications of novel drug design and heterogeneity of concurrent bipolar maintenance treatments","volume":"3","author":"Frye","year":"2015","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.jad.2016.02.050_bib13","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1176\/appi.ajp.2007.06060981","article-title":"A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression","volume":"164","author":"Frye","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2016.02.050_bib14","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0165-0327(14)70005-9","article-title":"Current landscape, unmet needs, and future directions for treatment of bipolar depression","volume":"169","author":"Frye","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.02.050_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jad.2012.04.041","article-title":"Suicidal behavior in bipolar disorder: epidemiology, characteristics and major risk factors","volume":"143","author":"Gonda","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.02.050_bib16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1185\/030079906X100050","article-title":"The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy","volume":"22","author":"Harsh","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2016.02.050_bib17","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rmed.2006.06.007","article-title":"Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea\/hypopnea syndrome","volume":"101","author":"Hirshkowitz","year":"2007","journal-title":"Respir. Med."},{"key":"10.1016\/j.jad.2016.02.050_bib18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2016.02.050_bib19","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0165-0327(14)70007-2","article-title":"Managing the side effects associated with commonly used treatments for bipolar depression","volume":"169","author":"Kemp","year":"2014","journal-title":"J. Affect. Disord."},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2016.02.050_bib20","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0165-0327(14)70006-0","article-title":"Balancing benefits and harms of treatments for acute bipolar depression","volume":"169","author":"Ketter","year":"2014","journal-title":"J. Affect. Disord"},{"key":"10.1016\/j.jad.2016.02.050_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jad.2015.04.012","article-title":"Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder","volume":"181","author":"Ketter","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2016.02.050_bib22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1399-5618.2007.00467.x","article-title":"Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder","volume":"9","author":"Kupka","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2016.02.050_bib23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1176\/appi.ajp.163.2.232","article-title":"Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers","volume":"163","author":"Leverich","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2016.02.050_bib24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2016.02.050_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2016.02.050_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000235985","article-title":"Low-dose buspirone, melatonin and low-dose bupropion added to mood stabilizers for severe treatment-resistant bipolar depression","volume":"78","author":"Nierenberg","year":"2009","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2016.02.050_bib27","unstructured":"Nuvigil [package insert], 2015. Teva Pharmaceuticals USA, Inc. North Wales, PA."},{"key":"10.1016\/j.jad.2016.02.050_bib28","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4088\/JCP.v64n0610","article-title":"Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method","volume":"64","author":"Post","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2016.02.050_bib29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.clinthera.2006.05.013","article-title":"Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea\/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults","volume":"28","author":"Roth","year":"2006","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jad.2016.02.050_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/WNF.0000000000000011","article-title":"Bupropion as an add-on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence","volume":"37","author":"Sepede","year":"2014","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jad.2016.02.050_bib31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4088\/JCP.09r05385gre","article-title":"Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis","volume":"72","author":"Sidor","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2016.02.050_bib32","doi-asserted-by":"crossref","unstructured":"World Health Organization, 2008. The global burden of disease. 2004 update. Available at: \u3008http:\/\/www.who.int\/healthinfo\/global_burden_disease\/2004_report_update\/en\/index.html\u3009 (accessed 23.04.15).","DOI":"10.1016\/S0262-1762(04)00136-1"},{"key":"10.1016\/j.jad.2016.02.050_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1192\/bjp.bp.114.147587","article-title":"Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: randomised double-blind placebo-controlled trial","volume":"208","author":"Yatham","year":"2016","journal-title":"Br. J. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715307795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715307795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T15:15:49Z","timestamp":1748790949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032715307795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":33,"alternative-id":["S0165032715307795"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2016.02.050","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term safety and efficacy of armodafinil in bipolar depression: A 6-month open-label extension study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2016.02.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}